A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

Researchers have produced a new mouse model that replicates how the most common form of human eye cancer develops over time. The model recreates the same step-by-step genetic changes found in patients ...

Stanford University scientists have found that erythropoietin (EPO), a protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells also plays a surprising, ...

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new ...

By HealthDay Staff HealthDay ReporterWEDNESDAY, March 11, 2026 (HealthDay News) — From cobblers to smoothies, dark sweet ...

Scientists at Oregon Health & Science University have developed a new molecule that could open the door to treating triple-negative breast cancer, one of the most aggressive and difficult-to-treat ...

Now, a research team from the Institute of Process Engineering (IPE) at the Chinese Academy of Sciences has developed a new helper molecule called FACE.